| Website | laurantis.com |
| Category | BioTech |
| Phone | 358-(0)2-4788-378 |
| info@laurantis.com | |
| Employees |
| TOTAL | $7.09M |
| FUNDING TOTAL | $7.09M |
| Venture Round, 9/12 Broadview Ventures Inveni Capital | €5.64M |
Laurantis Pharma Oy is a specialty pharmaceutical development company with a broad, clinical-stage portfolio in three therapeutic areas: dermatology, ophthalmology, and oncology. Using two proprietary technologies, Laurantis is developing first-in-class products for commercially and medically significant niche indications in these areas. Laurantis was formed in December 2010 through a merger of the Finnish drug development companies Oy Lx Therapies Ltd and BioCis Pharma Oy.
